Clinical approach to the diagnosis and treatment of cystic fibrosis and CFTR-related disorders
暂无分享,去创建一个
J. Mainz | R. Michl | J. Hentschel | J. Beck | H. Tabori | Harold Tabori
[1] A. Potter,et al. Physiotherapy for cystic fibrosis in Australia and New Zealand: A clinical practice guideline* , 2016, Respirology.
[2] L. Guillot,et al. Translating the genetics of cystic fibrosis to personalized medicine. , 2016, Translational research : the journal of laboratory and clinical medicine.
[3] J. Rommens,et al. Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis , 2015, Nature Communications.
[4] J. Singer,et al. Association between Chronic Rhinosinusitis and Health-Related Quality of Life in Adults with Cystic Fibrosis. , 2015, Annals of the American Thoracic Society.
[5] Xiaohong Huang,et al. Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. , 2015, The New England journal of medicine.
[6] W. Fokkens,et al. Sinonasal manifestations of cystic fibrosis: a correlation between genotype and phenotype? , 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[7] T. McKeever,et al. Rate of improvement of CF life expectancy exceeds that of general population—Observational death registration study , 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[8] S. Peltz,et al. Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial. , 2014, The Lancet. Respiratory medicine.
[9] A. Hinzpeter,et al. Genetics of cystic fibrosis: CFTR mutation classifications toward genotype-based CF therapies. , 2014, The international journal of biochemistry & cell biology.
[10] W. Cichy,et al. Liver disease in cystic fibrosis , 2014, Przeglad gastroenterologiczny.
[11] J. Mainz,et al. A Patient Nicknamed ‘Saline’: Atypical Course with Cystic Fibrosis , 2013, Klinische Pädiatrie.
[12] George P Patrinos,et al. Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene , 2013, Nature Genetics.
[13] J. Mainz,et al. Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation. , 2013, American journal of respiratory and critical care medicine.
[14] Peter D Sly,et al. Risk factors for bronchiectasis in children with cystic fibrosis. , 2013, The New England journal of medicine.
[15] N. Derichs. Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis , 2013, European Respiratory Review.
[16] David Y. Thomas,et al. Novel pharmacological strategies to treat cystic fibrosis. , 2013, Trends in pharmacological sciences.
[17] J. Clancy,et al. Personalized medicine in cystic fibrosis: dawning of a new era. , 2012, American journal of respiratory and critical care medicine.
[18] P. Quinton,et al. β-adrenergic sweat secretion as a diagnostic test for cystic fibrosis. , 2012, American journal of respiratory and critical care medicine.
[19] P. Durie,et al. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis. , 2012, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[20] K. Jarvi,et al. Comparing the American and European diagnostic guidelines for cystic fibrosis: same disease, different language? , 2012, Thorax.
[21] J. Mainz,et al. Pathogenesis and Management of Nasal Polyposis in Cystic Fibrosis , 2012, Current Allergy and Asthma Reports.
[22] Matthias Griese,et al. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. , 2011, The New England journal of medicine.
[23] B. Kerem,et al. Recommendations for the classification of diseases as CFTR-related disorders. , 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[24] G. Cutting,et al. Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function. , 2010, The Journal of pediatrics.
[25] J. Mainz,et al. Management of chronic rhinosinusitis in CF. , 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[26] O. Sommerburg,et al. European best practice guidelines for cystic fibrosis neonatal screening. , 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[27] P. Farrell,et al. The prevalence of cystic fibrosis in the European Union. , 2008, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[28] Vicky A Legrys,et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. , 2008, The Journal of pediatrics.
[29] A. Moran,et al. Management of cystic fibrosis‐related diabetes , 2008, Pediatric diabetes.
[30] S. Paranjape,et al. Atypical Cystic Fibrosis and CFTR-Related Diseases , 2008, Clinical reviews in allergy & immunology.
[31] M. Gadjeva,et al. Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis. , 2008, Trends in molecular medicine.
[32] C. Rudolph,et al. Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease , 2007, Nature Medicine.
[33] 卢杰,et al. Cystic fibrosis , 2007 .
[34] Charles A. Johnson,et al. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. , 2007, The Journal of pediatrics.
[35] M. Wilschanski,et al. Patterns of GI disease in adulthood associated with mutations in the CFTR gene , 2007, Gut.
[36] L. Naehrlich. [Sweat testing practices in German cystic fibrosis centres]. , 2007, Klinische Padiatrie.
[37] Dave P. Miller,et al. Infant Care Patterns at Epidemiologic Study of Cystic Fibrosis Sites That Achieve Superior Childhood Lung Function , 2007, Pediatrics.
[38] M. Stanton,et al. Cystic fibrosis mortality and survival in the UK: 1947–2003 , 2007, European Respiratory Journal.
[39] P. Kao,et al. Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection. , 2006, Chest.
[40] A. Hübler,et al. Cystic Fibrosis in 65- and 67-Year-Old Siblings , 2006, Respiration.
[41] F. Ratjen. Restoring airway surface liquid in cystic fibrosis. , 2006, The New England journal of medicine.
[42] G. Chaudry,et al. Abdominal manifestations of cystic fibrosis in children , 2006, Pediatric Radiology.
[43] K De Boeck,et al. Cystic fibrosis: terminology and diagnostic algorithms , 2005, Thorax.
[44] J. Dankert-Roelse,et al. Review of outcomes of neonatal screening for cystic fibrosis versus non-screening in Europe. , 2005, The Journal of pediatrics.
[45] F. Accurso,et al. Complications associated with symptomatic diagnosis in infants with cystic fibrosis. , 2005, The Journal of pediatrics.
[46] R. Parad,et al. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm. , 2005, The Journal of pediatrics.
[47] A. Moran,et al. Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. , 2005, Diabetes care.
[48] Massimiliano Mascherini,et al. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients , 2005, European Respiratory Journal.
[49] K. Gaskin,et al. The influence of newborn screening for cystic fibrosis on pulmonary outcomes in new South Wales. , 2005, The Journal of pediatrics.
[50] M. Rosenfeld. Overview of published evidence on outcomes with early diagnosis from large US observational studies. , 2005, The Journal of pediatrics.
[51] M. Kosorok,et al. Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough! , 2005, The Journal of pediatrics.
[52] N. Høiby,et al. Eradication of early Pseudomonas aeruginosa infection. , 2005, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[53] E. Kerem,et al. Standards of care for patients with cystic fibrosis: a European consensus. , 2005, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[54] M. Rosenfeld,et al. Update on cystic fibrosis epidemiology , 2004, Current opinion in pulmonary medicine.
[55] K. Kunzelmann,et al. Assessment of CFTR function in rectal biopsies for the diagnosis of cystic fibrosis. , 2004, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[56] J. Baumer. Evidence based guidelines for the performance of the sweat test for the investigation of cystic fibrosis in the UK , 2003, Archives of disease in childhood.
[57] M. Boyle. Nonclassic cystic fibrosis and CFTR-related diseases , 2003, Current opinion in pulmonary medicine.
[58] A. Morabito,et al. Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome , 2002, Hepatology.
[59] J. Haddow,et al. Updated assessment of cystic fibrosis mutation frequencies in non-Hispanic Caucasians , 2002, Genetics in Medicine.
[60] M. Kosorok,et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition , 2001, Pediatric pulmonology.
[61] J. Emerson,et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. , 2001, The Journal of infectious diseases.
[62] B. Strandvik,et al. Electrogenic ion transport in duodenum, an aid in cystic fibrosis diagnosis. , 2000, Scandinavian journal of gastroenterology.
[63] C. Férec,et al. Neonatal screening for cystic fibrosis in Brittany, France: assessment of 10 years' experience and impact on prenatal diagnosis , 2000, The Lancet.
[64] G. Pier,et al. Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[65] R. Wyllie. Gastrointestinal Manifestations of Cystic Fibrosis , 1999, Clinical pediatrics.
[66] B. Strandvik,et al. Natural history of liver disease in cystic fibrosis , 1999, Hepatology.
[67] Charles A. Johnson,et al. Epidemiologic study of cystic fibrosis: Design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada , 1999, Pediatric pulmonology.
[68] A. Spitzer,et al. Nutritional Benefits of Neonatal Screening for Cystic Fibrosis , 1998 .
[69] G. Cutting,et al. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. , 1998, The Journal of pediatrics.
[70] M. Kosorok,et al. Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis. , 1997, Pediatrics.
[71] M. Kosorok,et al. Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. , 1997, The New England journal of medicine.
[72] B. Kerem,et al. Genotype‐phenotype correlations in cystic fibrosis , 1996, Pediatric pulmonology.
[73] C. Lamers,et al. Genetic and clinical features of patients with cystic fibrosis diagnosed after the age of 16 years. , 1995, Thorax.
[74] J. Dodge. Male fertility in cystic fibrosis , 1995, The Lancet.
[75] S. Pitzalis,et al. A specific cystic fibrosis mutation (T3381) associated with the phenotype of isolated hypotonic dehydration. , 1995, The Journal of pediatrics.
[76] H. Veeze,et al. Diagnosis of cystic fibrosis. , 1995, The Netherlands journal of medicine.
[77] M. Knowles,et al. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. , 1995, Human gene therapy.
[78] M. Welsh,et al. Normal sweat chloride values do not exclude the diagnosis of cystic fibrosis. , 1995, American journal of respiratory and critical care medicine.
[79] M. Konstan,et al. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. , 1994, American journal of respiratory and critical care medicine.
[80] B. Kerem,et al. Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849 + 10 kb C → T mutation , 1993, The Lancet.
[81] M. Welsh,et al. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis , 1993, Cell.
[82] M. Corey,et al. The cystic fibrosis gene and resting energy expenditure. , 1991, The Journal of pediatrics.
[83] H. D. de Jonge,et al. Ion transport abnormalities in rectal suction biopsies from children with cystic fibrosis. , 1991, Gastroenterology.
[84] H. Levison,et al. Appendicitis in cystic fibrosis. , 1991, Archives of disease in childhood.
[85] K. Gaskin,et al. Pancreatic fluid secretion and protein hyperconcentration in cystic fibrosis. , 1985, The New England journal of medicine.
[86] P. Gluckman,et al. Neonatal screening for cystic fibrosis, using immunoreactive trypsin assay in dried blood spots. , 1981, Clinica chimica acta; international journal of clinical chemistry.
[87] E. Bruck,et al. National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.
[88] H. Shwachman,et al. Water and electrolytes in cervical mucus from patients with cystic fibrosis. , 1973, Fertility and sterility.
[89] R E COOKE,et al. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. , 1959, Pediatrics.
[90] H. B. T. Brooks,et al. Diagnostic Methods , 1916, The Indian Medical Gazette.
[91] M. Brennan,et al. Cystic Fibrosis: A Review of Associated Phenotypes, Use of Molecular Diagnostic Approaches, Genetic Characteristics, Progress, and Dilemmas. , 2016, The Journal of molecular diagnostics : JMD.
[92] M. Amaral,et al. New pharmacological approaches for cystic fibrosis: promises, progress, pitfalls. , 2015, Pharmacology & therapeutics.
[93] B. Tümmler,et al. Nasal potential difference measurements in diagnosis of cystic fibrosis: an international survey. , 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[94] A Munck,et al. A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis. , 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[95] E. Kerem. Atypical CF and CF related diseases. , 2006, Paediatric respiratory reviews.
[96] M. Claustres. Molecular pathology of the CFTR locus in male infertility. , 2005, Reproductive biomedicine online.
[97] M. Kosorok,et al. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. , 2001, Pediatrics.
[98] L. Romano,et al. Uncommon presenting manifestations of cystic fibrosis: A clinical alert , 1995 .
[99] B. Wilcken. Reviews and Notes: Genetics: The Metabolic and Molecular Bases of Inherited Disease , 1995, Annals of Internal Medicine.
[100] L. Tsui,et al. Identification of the cystic fibrosis gene: genetic analysis. , 1989, Science.
[101] J. Gustafson,et al. Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.